PRINCIPAL FINANCIAL GROUP INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 115 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is 2.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$51,000
+37.8%
10,988
+3.1%
0.00%
Q4 2018$37,000
-67.0%
10,653
-4.3%
0.00%
Q3 2018$112,000
+43.6%
11,133
+3.4%
0.00%
Q2 2018$78,000
-1.3%
10,767
-17.6%
0.00%
Q1 2018$79,000
-30.7%
13,065
+9.9%
0.00%
Q4 2017$114,00011,8860.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2018
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders